HASNAIN RANGWALA: Open Payments
NPI 1669422820 · FREEHOLD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,621 in 221 payments from 25 companies in 2025. Trend: 2023 $3,842 · 2024 $4,491 · 2025 $3,621
Food & beverage: $3,273Consulting: $250Education: $98
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 37 | $502 |
| ABBVIE INC. | 35 | $435 |
| Regeneron Healthcare Solutions, Inc. | 19 | $280 |
| Medimetriks Pharmaceuticals, Inc. | 1 | $250 |
| Novartis Pharmaceuticals Corporation | 13 | $245 |
| Galderma Laboratories, L.P. | 18 | $234 |
| Janssen Biotech, Inc. | 12 | $206 |
| MAYNE PHARMA COMMERCIAL LLC | 11 | $202 |
| Amgen Inc. | 11 | $186 |
| Organon LLC | 12 | $175 |
Products named: Bimzelx, DUPIXENT, Neo-Synalar, SKYRIZI, NEMLUVIO, COSENTYX, TREMFYA, RINVOQ.
Industry payments across NJ — which companies pay providers there.
